ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PLYX vs COYA // REVENUE GROWTH (YOY)

Polaryx Therapeutics Inc. (NASDAQ) VS. Coya Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: PLYX 2 — COYA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLYX VS. COYA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PLYX COYA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.25% -11.50% +7.25 PLYX /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 123.60% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 6.08 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.5 27.5 +4.00 PLYX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $92.7M $93.4M -$648.7K COYA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PLYX REV COYA REV PLYX GROSS % COYA GROSS % PLYX FCF COYA FCF
FY 2025 $0 $7.9M — — -$3.9M -$10.7M
FY 2024 $0 $3.6M — — -$2.6M -$10.3M
FY 2023 — $6.0M — — — -$11.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLYX // BETA —
COYA // BETA —